Mancl J, Liang W, Bayhi N, Wei H, Carragher B, Potter C
bioRxiv. 2025; .
PMID: 39803525
PMC: 11722313.
DOI: 10.1101/2024.12.30.630732.
Hill E, Cunningham T
Neuronal Signal. 2024; 8(1):NS20230020.
PMID: 38222463
PMC: 10781659.
DOI: 10.1042/NS20230020.
Corraliza-Gomez M, Bermejo T, Lilue J, Rodriguez-Iglesias N, Valero J, Cozar-Castellano I
J Neuroinflammation. 2023; 20(1):233.
PMID: 37817156
PMC: 10566021.
DOI: 10.1186/s12974-023-02914-7.
Zhang H, Li X, Wang X, Xu J, Elefant F, Wang J
Animal Model Exp Med. 2023; 6(1):3-9.
PMID: 36872303
PMC: 9986234.
DOI: 10.1002/ame2.12313.
Pan X, Coban Akdemir Z, Gao R, Jiang X, Sheynkman G, Wu E
Brief Bioinform. 2023; 24(2).
PMID: 36752347
PMC: 10025433.
DOI: 10.1093/bib/bbad030.
Brain O-GlcNAcylation: From Molecular Mechanisms to Clinical Phenotype.
Uygar B, Lagerlof O
Adv Neurobiol. 2022; 29:255-280.
PMID: 36255678
DOI: 10.1007/978-3-031-12390-0_9.
O-GlcNAcylation: an important post-translational modification and a potential therapeutic target for cancer therapy.
Lu Q, Zhang X, Liang T, Bai X
Mol Med. 2022; 28(1):115.
PMID: 36104770
PMC: 9476278.
DOI: 10.1186/s10020-022-00544-y.
SIRT1 deficiency increases O-GlcNAcylation of tau, mediating synaptic tauopathy.
Yin X, Li Y, Fan X, Huang F, Qiu Y, Zhao C
Mol Psychiatry. 2022; 27(10):4323-4334.
PMID: 35879403
DOI: 10.1038/s41380-022-01689-2.
The interplay among oxidative stress, brain insulin resistance and AMPK dysfunction contribute to neurodegeneration in type 2 diabetes and Alzheimer disease.
Barone E, Di Domenico F, Perluigi M, Butterfield D
Free Radic Biol Med. 2021; 176:16-33.
PMID: 34530075
PMC: 8595768.
DOI: 10.1016/j.freeradbiomed.2021.09.006.
Activity of Selected Group of Monoterpenes in Alzheimer's Disease Symptoms in Experimental Model Studies-A Non-Systematic Review.
Wojtunik-Kulesza K, Rudkowska M, Kasprzak-Drozd K, Oniszczuk A, Borowicz-Reutt K
Int J Mol Sci. 2021; 22(14).
PMID: 34298986
PMC: 8306454.
DOI: 10.3390/ijms22147366.
Impact of Genetic Risk Factors for Alzheimer's Disease on Brain Glucose Metabolism.
Cho S, Lee H, Seo J
Mol Neurobiol. 2021; 58(6):2608-2619.
PMID: 33479841
DOI: 10.1007/s12035-021-02297-x.
Role of -Linked -Acetylglucosamine Protein Modification in Cellular (Patho)Physiology.
Chatham J, Zhang J, Wende A
Physiol Rev. 2020; 101(2):427-493.
PMID: 32730113
PMC: 8428922.
DOI: 10.1152/physrev.00043.2019.
Ginsenoside Rb1 Improves Cognitive Impairment Induced by Insulin Resistance through Cdk5/p35-NMDAR-IDE Pathway.
Yang R, Jiang X, He X, Liang D, Sun S, Zhou G
Biomed Res Int. 2020; 2020:3905719.
PMID: 32550230
PMC: 7256773.
DOI: 10.1155/2020/3905719.
Modelling mitochondrial dysfunction in Alzheimer's disease using human induced pluripotent stem cells.
Hawkins K, Duchen M
World J Stem Cells. 2019; 11(5):236-253.
PMID: 31171953
PMC: 6545525.
DOI: 10.4252/wjsc.v11.i5.236.
Association between selected cholesterol-related gene polymorphisms and Alzheimer's disease in a Turkish cohort.
Guven G, Vurgun E, Bilgic B, Hanagasi H, Gurvit H, Ozer E
Mol Biol Rep. 2019; 46(2):1701-1707.
PMID: 30684189
DOI: 10.1007/s11033-019-04619-8.
Nutrient regulation of signaling and transcription.
Hart G
J Biol Chem. 2019; 294(7):2211-2231.
PMID: 30626734
PMC: 6378989.
DOI: 10.1074/jbc.AW119.003226.
O-GlcNAc cycling in the developing, adult and geriatric brain.
Lagerlof O
J Bioenerg Biomembr. 2018; 50(3):241-261.
PMID: 29790000
PMC: 5984647.
DOI: 10.1007/s10863-018-9760-1.
Insulin degrading enzyme contributes to the pathology in a mixed model of Type 2 diabetes and Alzheimer's disease: possible mechanisms of IDE in T2D and AD.
Li H, Wu J, Zhu L, Sha L, Yang S, Wei J
Biosci Rep. 2017; 38(1).
PMID: 29222348
PMC: 6435468.
DOI: 10.1042/BSR20170862.
Bile acid TUDCA improves insulin clearance by increasing the expression of insulin-degrading enzyme in the liver of obese mice.
Vettorazzi J, Kurauti M, Soares G, Borck P, Ferreira S, Branco R
Sci Rep. 2017; 7(1):14876.
PMID: 29093479
PMC: 5665899.
DOI: 10.1038/s41598-017-13974-0.
Amyloid beta: structure, biology and structure-based therapeutic development.
Chen G, Xu T, Yan Y, Zhou Y, Jiang Y, Melcher K
Acta Pharmacol Sin. 2017; 38(9):1205-1235.
PMID: 28713158
PMC: 5589967.
DOI: 10.1038/aps.2017.28.